{"count": 13, "results": [{"_id": "32601620", "pmid": 32601620, "pmcid": "PMC7323959", "title": "Prospective Evaluation of Effect of Metformin on Activation of AMP-activated Protein Kinase (AMPK) and Disease Control in a Sub-group Analysis of Patients with GI Malignancies", "journal": "J Cell Signal", "authors": ["Godara A", "Siddiqui NS", "Hachem H", "Tsichlis PN", "Martell RE", "Saif MW"], "date": "2020-01-01T00:00:00Z", "doi": "10.33696/Signaling.1.008", "meta_date_publication": "2020", "meta_volume": "1", "meta_issue": "2", "meta_pages": "35-41", "score": 50287.867, "text_hl": "This sub-group analysis on @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@GI cancers@@@ revealed an increase in @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ phosphorylation on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, further reassuring the potential role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in preventive and treatment settings in @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@GI malignancies@@@. ", "citations": {"NLM": "Godara A, Siddiqui NS, Hachem H, Tsichlis PN, Martell RE, Saif MW. Prospective Evaluation of Effect of Metformin on Activation of AMP-activated Protein Kinase (AMPK) and Disease Control in a Sub-group Analysis of Patients with GI Malignancies J Cell Signal. 2020;1(2):35-41. PMID: 32601620", "BibTeX": "@article{32601620, title={Prospective Evaluation of Effect of Metformin on Activation of AMP-activated Protein Kinase (AMPK) and Disease Control in a Sub-group Analysis of Patients with GI Malignancies}, author={Godara A and Siddiqui NS and Hachem H and Tsichlis PN and Martell RE and Saif MW}, journal={J Cell Signal}, volume={1}, number={2}, pages={35-41}}"}}, {"_id": "34007128", "pmid": 34007128, "pmcid": "PMC8108031", "title": "Repurposing metformin for the treatment of gastrointestinal cancer", "journal": "World J Gastroenterol", "authors": ["Cunha Júnior AD", "Bragagnoli AC", "Costa FO", "Carvalheira JBC"], "date": "2021-05-07T00:00:00Z", "doi": "10.3748/wjg.v27.i17.1883", "meta_date_publication": "2021 May 7", "meta_volume": "27", "meta_issue": "17", "meta_pages": "1883-1904", "score": 50282.867, "text_hl": "Repurposing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for the treatment of @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@gastrointestinal cancer@@@", "citations": {"NLM": "Cunha Júnior AD, Bragagnoli AC, Costa FO, Carvalheira JBC. Repurposing metformin for the treatment of gastrointestinal cancer World J Gastroenterol. 2021 May 7;27(17):1883-1904. PMID: 34007128", "BibTeX": "@article{34007128, title={Repurposing metformin for the treatment of gastrointestinal cancer}, author={Cunha Júnior AD and Bragagnoli AC and Costa FO and Carvalheira JBC}, journal={World J Gastroenterol}, volume={27}, number={17}, pages={1883-1904}}"}}, {"_id": "33744985", "pmid": 33744985, "title": "Anticancer potential of metformin: focusing on gastrointestinal cancers.", "journal": "Cancer Chemother Pharmacol", "authors": ["Khezri MR", "Malekinejad H", "Majidi-Zolbanin N", "Ghasemnejad-Berenji M"], "date": "2021-05-01T00:00:00Z", "doi": "10.1007/s00280-021-04256-8", "meta_date_publication": "2021 May", "meta_volume": "87", "meta_issue": "5", "meta_pages": "587-598", "score": 50278.867, "text_hl": "Anticancer potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@: focusing on @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@gastrointestinal cancers@@@.", "citations": {"NLM": "Khezri MR, Malekinejad H, Majidi-Zolbanin N, Ghasemnejad-Berenji M. Anticancer potential of metformin: focusing on gastrointestinal cancers. Cancer Chemother Pharmacol. 2021 May;87(5):587-598. PMID: 33744985", "BibTeX": "@article{33744985, title={Anticancer potential of metformin: focusing on gastrointestinal cancers.}, author={Khezri MR and Malekinejad H and Majidi-Zolbanin N and Ghasemnejad-Berenji M}, journal={Cancer Chemother Pharmacol}, volume={87}, number={5}, pages={587-598}}"}}, {"_id": "33604594", "pmid": 33604594, "title": "Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis.", "journal": "Int J Clin Endocrinol Metab", "authors": ["Hevroni G", "Skwiersky S", "Zhyvotovska A", "McFarlane SI"], "date": "2020-01-01T00:00:00Z", "doi": "10.17352/ijcem.000052", "meta_date_publication": "2020", "meta_volume": "6", "meta_issue": "1", "meta_pages": "035-41", "score": 50266.883, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use and the Risk of @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@Gastrointestinal Malignancies@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic@@@ Populations: A Meta-Analysis.", "citations": {"NLM": "Hevroni G, Skwiersky S, Zhyvotovska A, McFarlane SI. Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis. Int J Clin Endocrinol Metab. 2020;6(1):035-41. PMID: 33604594", "BibTeX": "@article{33604594, title={Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis.}, author={Hevroni G and Skwiersky S and Zhyvotovska A and McFarlane SI}, journal={Int J Clin Endocrinol Metab}, volume={6}, number={1}, pages={035-41}}"}}, {"_id": "32987433", "pmid": 32987433, "title": "Efficacy of Metformin and Chemotherapeutic Agents on the Inhibition of Colony Formation and Shh/Gli1 Pathway: Metformin/Docetaxel Versus Metformin/5-Fluorouracil.", "journal": "Drug Res (Stuttg)", "authors": ["Fatehi-Agdam M", "Vatankhah MA", "Panahizadeh R", "Jeddi F", "Najafzadeh N"], "date": "2021-01-01T00:00:00Z", "doi": "10.1055/a-1248-9008", "meta_date_publication": "2021 Jan", "meta_volume": "71", "meta_issue": "1", "meta_pages": "17-25", "score": 50262.227, "text_hl": "Despite their potent anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ effects, chemoresistance occurs in metastatic @DISEASE_Stomach_Neoplasms @DISEASE_MESH:D013274 @@@gastric cancer@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, a popular anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ drug, has been proven to have potent anticancer effects on @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@gastrointestinal cancers@@@. ", "citations": {"NLM": "Fatehi-Agdam M, Vatankhah MA, Panahizadeh R, Jeddi F, Najafzadeh N. Efficacy of Metformin and Chemotherapeutic Agents on the Inhibition of Colony Formation and Shh/Gli1 Pathway: Metformin/Docetaxel Versus Metformin/5-Fluorouracil. Drug Res (Stuttg). 2021 Jan;71(1):17-25. PMID: 32987433", "BibTeX": "@article{32987433, title={Efficacy of Metformin and Chemotherapeutic Agents on the Inhibition of Colony Formation and Shh/Gli1 Pathway: Metformin/Docetaxel Versus Metformin/5-Fluorouracil.}, author={Fatehi-Agdam M and Vatankhah MA and Panahizadeh R and Jeddi F and Najafzadeh N}, journal={Drug Res (Stuttg)}, volume={71}, number={1}, pages={17-25}}"}}, {"_id": "33105165", "pmid": 33105165, "pmcid": "PMC7587422", "title": "Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea", "journal": "Clin Transl Gastroenterol", "authors": ["You JH", "Song SO", "Kang MJ", "Cho YY", "Kim SW", "Suh SH", "Lee S", "Lee YH", "Lee BW"], "date": "2020-11-01T00:00:00Z", "doi": "10.14309/ctg.0000000000000254", "meta_date_publication": "2020 Nov", "meta_volume": "11", "meta_issue": "11", "meta_pages": "e00254", "score": 50260.71, "text_hl": "Clinical studies have produced conflicting results on the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@gastrointestinal cancer@@@ development. ", "citations": {"NLM": "You JH, Song SO, Kang MJ, Cho YY, Kim SW, Suh SH, Lee S, Lee YH, Lee BW. Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea Clin Transl Gastroenterol. 2020 Nov;11(11):e00254. PMID: 33105165", "BibTeX": "@article{33105165, title={Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea}, author={You JH and Song SO and Kang MJ and Cho YY and Kim SW and Suh SH and Lee S and Lee YH and Lee BW}, journal={Clin Transl Gastroenterol}, volume={11}, number={11}, pages={e00254}}"}}, {"_id": "37446172", "pmid": 37446172, "pmcid": "PMC10342009", "title": "The Role of Activating Transcription Factor 3 in Metformin's Alleviation of Gastrointestinal Injury Induced by Restraint Stress in Mice", "journal": "Int J Mol Sci", "authors": ["Siwakoti B", "Lien TS", "Lin YY", "Pethaperumal S", "Hung SC", "Sun DS", "Cheng CF", "Chang HH"], "date": "2023-07-01T00:00:00Z", "doi": "10.3390/ijms241310995", "meta_date_publication": "2023 Jul 1", "meta_volume": "24", "meta_issue": "13", "meta_pages": "", "score": 50253.363, "text_hl": "These actions contribute to the protective effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ against @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@gastrointestinal (GI) tract injury@@@. ", "citations": {"NLM": "Siwakoti B, Lien TS, Lin YY, Pethaperumal S, Hung SC, Sun DS, Cheng CF, Chang HH. The Role of Activating Transcription Factor 3 in Metformin's Alleviation of Gastrointestinal Injury Induced by Restraint Stress in Mice Int J Mol Sci. 2023 Jul 1;24(13):. PMID: 37446172", "BibTeX": "@article{37446172, title={The Role of Activating Transcription Factor 3 in Metformin's Alleviation of Gastrointestinal Injury Induced by Restraint Stress in Mice}, author={Siwakoti B and Lien TS and Lin YY and Pethaperumal S and Hung SC and Sun DS and Cheng CF and Chang HH}, journal={Int J Mol Sci}, volume={24}, number={13}}"}}, {"_id": "34368808", "pmid": 34368808, "title": "The First Study Evaluating the Safety of Pre-Surgery Administration of Metformin in Patients with Colorectal and other Gastrointestinal Cancers and Effect on Cancer Stem Cells.", "journal": "Cancer Med J", "authors": ["Saif MW", "Rajagopal S", "Caplain J", "Goodman MD", "Popowich D", "Orkin BA", "Tsichlis PN", "Martell R"], "date": "2021-09-01T00:00:00Z", "meta_date_publication": "2021 Sep", "meta_volume": "4", "meta_issue": "Suppl 4", "meta_pages": "1-10", "score": 50250.727, "text_hl": "Comparison of markers of CCSC results showed that expression of @GENE_PROM1 @GENE_8842 @@@CD133@@@, @GENE_POU5F1 @GENE_5460 @@@OCT4@@@ and @GENE_NANOG @GENE_79923 @@@NANOG@@@ expression were decreased following @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. CONCLUSIONS: Our pilot study showed feasibility of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ before surgery in @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@GI cancers@@@ and indicated impact on CSC. ", "citations": {"NLM": "Saif MW, Rajagopal S, Caplain J, Goodman MD, Popowich D, Orkin BA, Tsichlis PN, Martell R. The First Study Evaluating the Safety of Pre-Surgery Administration of Metformin in Patients with Colorectal and other Gastrointestinal Cancers and Effect on Cancer Stem Cells. Cancer Med J. 2021 Sep;4(Suppl 4):1-10. PMID: 34368808", "BibTeX": "@article{34368808, title={The First Study Evaluating the Safety of Pre-Surgery Administration of Metformin in Patients with Colorectal and other Gastrointestinal Cancers and Effect on Cancer Stem Cells.}, author={Saif MW and Rajagopal S and Caplain J and Goodman MD and Popowich D and Orkin BA and Tsichlis PN and Martell R}, journal={Cancer Med J}, volume={4}, number={Suppl 4}, pages={1-10}}"}}, {"_id": "40293640", "pmid": 40293640, "title": "Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials.", "journal": "Int J Clin Pharm", "authors": ["Xu B", "Kang B", "Li S", "Chen J", "Zhou J"], "date": "2025-04-28T00:00:00Z", "doi": "10.1007/s11096-025-01924-0", "meta_date_publication": "2025 Apr 28", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50246.22, "text_hl": "Subgroup analysis indicated a significant reduction in the risk of @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@gastrointestinal cancer@@@ with @GENE_SLC5A2 @GENE_6524 @@@SGLT2@@@ inhibitors compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (RR 0.23; 95%CI 0.06-0.95; p = 0.04). ", "citations": {"NLM": "Xu B, Kang B, Li S, Chen J, Zhou J. Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials. Int J Clin Pharm. 2025 Apr 28;():. PMID: 40293640", "BibTeX": "@article{40293640, title={Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials.}, author={Xu B and Kang B and Li S and Chen J and Zhou J}, journal={Int J Clin Pharm}}"}}, {"_id": "32274150", "pmid": 32274150, "pmcid": "PMC7138989", "title": "Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study", "journal": "J Thorac Dis", "authors": ["He HH", "Fu JH", "Hao ZX", "Wu HF", "Zhong Q", "Wang F", "Liu HH", "Gu XS", "Wang B", "Huang HD", "Li ZY", "He JX"], "date": "2020-03-01T00:00:00Z", "doi": "10.21037/jtd.2019.12.98", "meta_date_publication": "2020 Mar", "meta_volume": "12", "meta_issue": "3", "meta_pages": "830-838", "score": 50243.992, "text_hl": "@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes mellitus@@@ is a recognized risk factor for @DISEASE_Esophageal_Squamous_Cell_Carcinoma @DISEASE_MESH:D000077277 @@@esophageal squamous cell carcinomas@@@ (@DISEASE_Esophageal_Squamous_Cell_Carcinoma @DISEASE_MESH:D000077277 @@@ESCC@@@), and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is a recognized protective factor for some @<m>DISEASE_Gastrointestinal_Neoplasms</m> @DISEASE_MESH:D005770 @@@gastrointestinal tumors@@@. ", "citations": {"NLM": "He HH, Fu JH, Hao ZX, Wu HF, Zhong Q, Wang F, Liu HH, Gu XS, Wang B, Huang HD, Li ZY, He JX. Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study J Thorac Dis. 2020 Mar;12(3):830-838. PMID: 32274150", "BibTeX": "@article{32274150, title={Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study}, author={He HH and Fu JH and Hao ZX and Wu HF and Zhong Q and Wang F and Liu HH and Gu XS and Wang B and Huang HD and Li ZY and He JX}, journal={J Thorac Dis}, volume={12}, number={3}, pages={830-838}}"}}]}